tiprankstipranks
Trending News
More News >
AstraZeneca (AZN)
:AZN
US Market
Advertisement

AstraZeneca (AZN) Technical Analysis

Compare
7,493 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
AstraZeneca’s (AZN) Moving Averages Convergence Divergence (MACD) indicator is 1.70, suggesting AstraZeneca is a Buy.
AstraZeneca’s (AZN) 20-Day exponential moving average is 89.39, while AstraZeneca’s (AZN) share price is $90.18, making it a Buy.
AstraZeneca’s (AZN) 50-Day exponential moving average is 86.07, while AstraZeneca’s (AZN) share price is $90.18, making it a Buy.

AstraZeneca (AZN) Pivot Points

Dec 08, 2025, 01:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
88.48
89.12
89.58
90.22
90.68
91.32
91.78
Fibonacci
89.12
89.54
89.80
90.22
90.64
90.90
91.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AstraZeneca (AZN) Moving Averages

Dec 08, 2025, 01:34 PM
Period
Simple
Exponential
MA5
90.35Sell
90.53Sell
MA10
91.36Sell
90.51Sell
MA20
89.84Buy
89.39Buy
MA50
85.67Buy
86.07Buy
MA100
81.17Buy
82.22Buy
MA200
76.15Buy
77.29Buy
AstraZeneca’s (AZN) 10-Day exponential moving average is 90.51, while AstraZeneca’s (AZN) share price is $90.18, making it a Sell.
AstraZeneca’s (AZN) 100-Day exponential moving average is 82.22, while AstraZeneca’s (AZN) share price is $90.18, making it a Buy.
AstraZeneca’s (AZN) stock price is $90.18 and AstraZeneca’s (AZN) 50-day simple moving average is 85.67, creating a Buy signal.
AstraZeneca’s (AZN) stock price is $90.18 and AstraZeneca’s (AZN) 100-day simple moving average is 81.17, creating a Buy signal.
AstraZeneca’s (AZN) stock price is $90.18 and AstraZeneca’s (AZN) 200-day simple moving average is 76.15, creating a Buy signal.

AstraZeneca (AZN) Technical Indicators

Dec 08, 2025, 01:34 PM
Name
Value
Implied Action
RSI (14)
57.55
Neutral
STOCH (9,6)
22.65
Neutral
STOCHRSI (14)
37.53
Neutral
MACD (12,26)
1.70
Buy
ADX (14)
31.38
Neutral
Williams %R
-68.42
Buy
CCI (14)
26.15
Neutral
ATR (14)
1.53
-
Ultimate Oscillator
34.96
Neutral
ROC
1.21
Buy
AstraZeneca’s (AZN) Relative Strength Index (RSI) is 57.55, creating a Neutral signal.
AstraZeneca’s (AZN) Trend Strength Indicator (ADX) is 31.38, creating a Neutral signal.
AstraZeneca’s (AZN) Commodity Channel Index (CCI) is 26.15, creating a Neutral signal.
AstraZeneca’s (AZN) Price Rate of Change (ROC) is 1.21, creating a Buy signal.

FAQ

Is AZN a Buy, Hold, or Sell?
Based on AZN’s technical indicators, AZN is a Buy.
    What is AZN’s RSI (14)?
    AZN’s RSI (14) is 57.55, which suggests AZN is a Neutral.
      What is AZN’s MACD?
      AZN’s MACD is 1.70, which suggests AZN is a Buy.
        What is AZN’s 5-day moving average?
        AZN’s 5-day moving average is 90.35, which suggests AZN is a Sell.
          What is AZN’s 20-day moving average?
          AZN 20-day moving average is 89.84, which suggests AZN is a Buy.
            What is AZN’s 50-day moving average?
            AZN’s 50-day moving average is 85.67, which suggests AZN is a Buy.
              What is AZN’s 200-day moving average?
              AZN’s 200-day moving average is 76.15, which suggests AZN is a Buy.
                What is AZN’s Williams % R (14)?
                AZN’s Williams % R (14) is -68.42, which suggests AZN is a Buy.
                  What is AZN’s CCI (14)?
                  AZN’s CCI (14) is 26.15, which suggests AZN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis